News

Avantor, Inc. a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced it…
Read More...

Merck, known as MSD outside the United States and Canada, today announced it has entered into a procurement agreement with the United States government for molnupiravir (MK-4482).…
Read More...

Arena Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation status to etrasimod, a highly selective, once-daily, oral…
Read More...

Know Labs, Inc. an emerging leader in non-invasive medical diagnostics, announced successful results from an independent pre-clinical study validating the company’s Bio-RFID platform…
Read More...

Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company at the forefront of stem cell-based delivery of oncolytic viruses, announced its partnership with GenScript ProBio,…
Read More...

Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, announced interim data of 503 patients from its Post Marketing Surveillance (PMS) study on…
Read More...

Scipher Medicine, a precision immunology company matching patients with the most effective therapy, in collaboration with Northeastern University; Brigham and Women’s Hospital, Harvard…
Read More...

Indivior PLC, announced that it is extending its leadership position in substance use disorder ("SUD") treatment by expanding into the under treated cannabis-related disorders,…
Read More...

Icosavax, Inc. announced the first subjects have been dosed with IVX-411, a virus-like particle (VLP) displaying the SARS-CoV-2 receptor-binding domain (RBD), in a Phase 1/2 clinical…
Read More...

BioCelerate, a subsidiary of TransCelerate BioPharma Inc. that focuses on identifying and developing pragmatic and tangible solutions to improve efficiencies in nonclinical research,…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines and Medison Pharma, a leading commercial partner for highly innovative therapies in…
Read More...

argenx SE a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, announced it will regain worldwide rights to its…
Read More...

Samyang Holdings signed an MOU to co-develop a vaccine for COVID-19 with “mCureX (CEO: Hong Sun-woo),” a subsidiary of a “OliX Pharmaceuticals (CEO: Lee Dong-ki),” a pharmaceutical…
Read More...

Biogen and Eisai, Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for ADUHELM™ (aducanumab-avwa) as the first and only Alzheimer’s…
Read More...

Ascletis Pharma Inc. announces that China National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) application for its drug candidate ASC42 to…
Read More...

Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, announced that it has submitted…
Read More...

Merck known as MSD outside the United States and Canada, announced it has completed the spinoff of Organon & Co. (Organon). “Today marks a significant milestone for both Merck…
Read More...

Bayer announced that it has entered into an agreement to acquire Noria Therapeutics Inc. (Noria) and PSMA Therapeutics Inc. Through this acquisition, Bayer will obtain exclusive rights…
Read More...

BioCryst Pharmaceuticals, Inc. announced that oral, once-daily ORLADEYO (berotralstat) is now available for patients with a prescription in Germany. ORLADEYO was approved by the…
Read More...

Moderna, Inc. announced that it has entered into an additional agreement with Lonza to support drug substance manufacturing for its global supply chain. The agreement will establish a…
Read More...